SBS 16th Annual Conference & Exhibition

Published: 25-Mar-2010

11 - 15 April 2010
Phoenix Convention Center, Phoenix, Arizona, US

The only non-profit scientific and industry conference focusing on molecular and cellular screening, the SBS conference brings together leading scientists from industry, government and academia to present new research and information.

Trending Articles

  1. CPhI North America 7-9 May 2024 | Exhibition | Pennsylvania, US
  2. ASGCT Annual Meeting 2024 7-11 May, 2024 | Meeting | Portland, OR
  3. BIO International Convention Digital 3-6 June, 2024 | Convention | San Diego, US
  4. KOREA CHEM 2023 18-21 April 2023 | Exhibition | Korea
  5. Cleanroom Conference UK 22–23 May 2024 | Exhibition | Birmingham, UK

You may also like

Research & Development

Curia expands biologics capabilities with access to Touchlight’s doggybone DNA

Curia collaborates with Touchlight to expand its mRNA manufacturing offering to enable access to enzymatic doggybone DNA (dbDNA)
Drug Delivery

Curia and MilliporeSigma sign deal for use of cell line for proteins and antibodies

Following this agreement, the CHOZN GS-/- cell line has been integrated into Curia’s cell line development workflow and is immediately available to Curia customers
Manufacturing

Curia reveals continuous-flow collaboration with Corning

Continuous flow chemistry is critical for the development and manufacture of pharmaceutical intermediates and APIs
Manufacturing

Chemistry meets biology: an integrated approach to developing and manufacturing medicines of the future

Until recently, chemists and biologists rarely needed to collaborate to develop a new large molecule drug, reports Chris Conway, President, Research and Development, Curia
Research & Development

AMRI manufactures lipid excipients for Pfizer-BioNTech COVID-19 vaccine

AMRI has been providing development, scale-up and manufacturing services at a number of its global R&D and production sites for several months
Manufacturing

ViralClear partners with CDMO on potential COVID-19 treatment Merimepodib

ViralClear Pharmaceuticals has partnered with Albany Molecular Research Inc (AMRI) on the manufacture of Merimepodib API either as a stand-alone treatment or in combination with other antiviral agents or immune modulator
Manufacturing

AMRI to acquire Euticals

Strategic transaction expands API development and manufacturing business
Subscribe now